Search Login Register

Diabetes Insipidus Summary

Description: A disease that is characterized by frequent urination, excretion of large amounts of dilute URINE, and excessive THIRST. Etiologies of diabetes insipidus include deficiency of antidiuretic hormone (also known as ADH or VASOPRESSIN) secreted by the NEUROHYPOPHYSIS, impaired KIDNEY response to ADH, and impaired hypothalamic regulation of thirst.

Key Drugs and Agents for Diabetes Insipidus

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Deamino Arginine Vasopressin (Desmopressin) : 12 outcomes 8 studies in 186 results : FDA 16 Generic
  2. Vasopressins (Vasopressin) : 7 outcomes 17 studies in 480 results : IBA
  3. Arginine Vasopressin (Argipressin) : 4 outcomes 6 studies in 88 results : IBA
  4. Hormones : 3 outcomes 11 studies in 223 results : IBA
  5. Hydrocortisone (Cortisol) : 3 outcomes 5 studies in 26 results : FDA 176 Generic
  6. Prednisolone (Predate) : 3 outcomes in 9 results : FDA 55 Generic
  7. Insulin (Novolin) : 2 outcomes 3 studies in 26 results : FDA 2
  8. Chlorpropamide : 2 outcomes 2 studies in 121 results : FDA 34 Generic
  9. Adrenocorticotropic Hormone (ACTH) : 2 outcomes 2 studies in 52 results : FDA 7
  10. Cyclophosphamide (Cytoxan) : 2 outcomes in 6 results : FDA 10 Generic
Show All >>

Diseases Related to Diabetes Insipidus

  1. Hypopituitarism (Sheehan's Syndrome)
  2. Diabetes Mellitus
  3. Hypothyroidism
  4. Dehydration (Water Stress)
  5. Neoplasm Metastasis (Metastasis)
Show All >>

Key Therapies for Diabetes Insipidus

Efficacy Chart >>
  1. Drug Therapy (Chemotherapy) : 7 outcomes in 31 results
  2. Radiotherapy : 3 outcomes in 13 results
  3. Hypophysectomy : 2 outcomes 2 studies in 14 results
  4. Ventriculoperitoneal Shunt : 1 outcome in 2 results
  5. Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) : 1 outcome in 1 result
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.